Source:http://linkedlifedata.com/resource/pubmed/id/11113291
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-1-26
|
pubmed:abstractText |
It is known that diabetic mice are less sensitive to the analgesic effect of morphine. Some factor(s) derived from mononuclear cells, e.g. interleukin-1beta (IL-1beta), may be responsible for the diminished analgesic effect of morphine in diabetic mice. Therefore, we examined direct effects of IL-1beta, intracerebroventricularly (i.c.v.), on morphine-induced analgesia, subcutaneously (s.c.), in diabetic and control mice by using the tail-flick test. Morphine at doses of 1, 2 and 5 mg/kg (s.c.) produced dose-dependent analgesia in diabetic and control mice but diabetic mice were less sensitive to the analgesic effect of morphine when compared to the controls. IL-1beta at a dose of 0.1 ng/mouse produced analgesia in control mice but not in diabetics, whereas IL-1beta at a dose of 10 ng/mouse produced a hyperalgesic effect both in diabetic and control mice. IL-1beta at a dose of 1 ng/mouse has neither an analgesic nor a hyperalgesic effect in control and diabetic mice. Administration of a neutral (neither analgesic nor hyperalgesic) dose of IL-1beta, 1 ng/mouse (i.c.v.), just prior to administration of morphine (s.c.) abolished the analgesic effect of morphine at doses of 1, 2 and 5 mg/kg in control mice and the analgesic effect of morphine became similar to that in diabetics. The diminished analgesic effect of morphine in diabetes was attenuated further with IL-1beta at a dose of 1 ng/mouse (i.c.v.). These results suggest that the decreased analgesic effect of morphine in diabetes may be related to IL-1beta.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0304-3959
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
39-45
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11113291-Analgesics, Opioid,
pubmed-meshheading:11113291-Animals,
pubmed-meshheading:11113291-Body Temperature,
pubmed-meshheading:11113291-Diabetes Mellitus, Experimental,
pubmed-meshheading:11113291-Dose-Response Relationship, Drug,
pubmed-meshheading:11113291-Drug Interactions,
pubmed-meshheading:11113291-Interleukin-1,
pubmed-meshheading:11113291-Male,
pubmed-meshheading:11113291-Mice,
pubmed-meshheading:11113291-Mice, Inbred BALB C,
pubmed-meshheading:11113291-Morphine,
pubmed-meshheading:11113291-Pain,
pubmed-meshheading:11113291-Pain Threshold,
pubmed-meshheading:11113291-Rectum,
pubmed-meshheading:11113291-Tail
|
pubmed:year |
2000
|
pubmed:articleTitle |
The interaction between IL-1beta and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice.
|
pubmed:affiliation |
Department of Pharmacology, School of Medicine, Gulhane Military Medical Academy, 06018, Etlik, Ankara, Turkey.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|